Although the bulk of gene therapy manufacturing is currently for clinical research, he said they must be prepared to meet the future needs. Because of that ...
https://www.google.com/url?rct=j&sa=t&url=https://biobuzz.io/center-for-breakthrough-medicines-taps-joerg-ahlgrimm-as-new-ceo/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNELWXxkzP48VzgLVkyDemg9jLAc9Q
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.